Keeler Thomas Management LLC Buys New Holdings in Zoetis Inc. $ZTS

Keeler Thomas Management LLC bought a new stake in shares of Zoetis Inc. (NYSE:ZTS) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 7,556 shares of the company’s stock, valued at approximately $1,178,000.

Several other institutional investors also recently bought and sold shares of the stock. Vanguard Group Inc. boosted its holdings in Zoetis by 0.5% during the 1st quarter. Vanguard Group Inc. now owns 41,556,164 shares of the company’s stock valued at $6,842,222,000 after acquiring an additional 189,287 shares during the period. Polen Capital Management LLC lifted its holdings in Zoetis by 17.6% in the 1st quarter. Polen Capital Management LLC now owns 8,796,847 shares of the company’s stock worth $1,448,401,000 after buying an additional 1,313,653 shares during the period. Northern Trust Corp lifted its holdings in Zoetis by 1.2% in the 1st quarter. Northern Trust Corp now owns 6,504,902 shares of the company’s stock worth $1,071,032,000 after buying an additional 78,508 shares during the period. Goldman Sachs Group Inc. lifted its holdings in Zoetis by 2.2% in the 1st quarter. Goldman Sachs Group Inc. now owns 5,146,024 shares of the company’s stock worth $847,293,000 after buying an additional 109,791 shares during the period. Finally, Brown Advisory Inc. lifted its holdings in Zoetis by 7.6% in the 1st quarter. Brown Advisory Inc. now owns 4,408,542 shares of the company’s stock worth $725,866,000 after buying an additional 312,746 shares during the period. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

ZTS has been the subject of several research reports. Leerink Partners lowered Zoetis from an “outperform” rating to a “market perform” rating and decreased their target price for the stock from $180.00 to $155.00 in a research report on Thursday, July 17th. UBS Group decreased their target price on Zoetis from $165.00 to $158.00 and set a “neutral” rating for the company in a research report on Monday. Argus reissued a “buy” rating and issued a $190.00 target price on shares of Zoetis in a research report on Tuesday, September 9th. Piper Sandler increased their target price on Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a research report on Monday, August 11th. Finally, Leerink Partnrs lowered Zoetis from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 17th. Four research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $195.00.

Zoetis Stock Down 0.2%

ZTS stock opened at $146.14 on Friday. Zoetis Inc. has a twelve month low of $139.34 and a twelve month high of $184.40. The company has a quick ratio of 1.04, a current ratio of 1.76 and a debt-to-equity ratio of 1.05. The firm has a market cap of $64.77 billion, a PE ratio of 25.15, a price-to-earnings-growth ratio of 2.35 and a beta of 0.90. The business has a 50 day moving average of $148.18 and a 200 day moving average of $153.50.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, August 5th. The company reported $1.76 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.14. The business had revenue of $2.46 billion during the quarter, compared to analyst estimates of $2.41 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The company’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same quarter last year, the company earned $1.56 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, research analysts forecast that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st will be issued a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 31st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. Zoetis’s dividend payout ratio (DPR) is presently 34.42%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.